ArticlePloS one2025
Comparison of serum lactate and lactate-derived ratios as prognostic biomarkers in pediatric dengue shock syndrome using supervised machine learning models.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tree-Based Machine Learning for Diagnostic Classification of Dengue Fever Using Routine Hematological Parameters: A Secondary Analysis of a Publicly Available Dataset.Diagnostics (Basel, Switzerland) · 2026Article
- Developing and validating a lactate-to-albumin ratio-enhanced score for mortality prediction in ICU patients with acute pulmonary embolism: a multi-cohort study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue shock syndrome (DSS), with critical complications encompassing mechanical ventilation (MV), dengue-associated acute liver failure (PALF), and encephalitis, is associated with high mortality in children. Although serum lactate is a recognized prognostic biomarker, it may not fully reflect the complex metabolic disturbances in DSS. Recent evidence suggests that lactate-derived indices, including lactate-to-albumin ratio (LAR) and lactate-to-bicarbonate ratio (LB), may enhance prognostic accuracy. This study aimed to evaluate and compare the predictive performance of the LAR, LB ratio, and serum lactate levels in pediatric DSS using machine learning approaches. METHODS AND
findingsWe conducted a secondary analysis of a retrospective cohort study involving children with DSS at a tertiary pediatric center in Vietnam (2013-2022). The primary composite endpoint included in-hospital mortality, MV, dengue-associated PALF and encephalitis. Predictors were selected based on clinical expertise, literature review, Akaike Information Criterion and Least Absolute Shrinkage and Selection Operator. Multiple supervised machine-learning algorithms - logistic regression, random forest (RF), support vector machine (SVM), k-nearest neighbor, naïve Bayes, AdaBoost, and XGBoost - were applied. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and feature importance was assessed using Shapley Additive Explanations (SHAP).
resultsOf the 524 eligible patients (median age: 8.7 years), 17% met the composite endpoint. At admission, LAR demonstrated superior discriminatory ability (AUC: 0.82; 95% CI: 0.76-0.87) compared to serum lactate (AUC: 0.72; 95% CI: 0.65-0.78) and LB ratio (AUC: 0.68; 95% CI: 0.62-0.74) (all p < 0.001). The Youden-index based optimal LAR cutoff was 1.25, whereas that for the LB ratio was 0.20. The RF, XGBoost and SVM models achieved the highest performance. SHAP analysis revealed that LAR was the most influential predictor among the lactate-based variables.
conclusionsLAR exceeded serum lactate and the LB ratio in predicting critical outcomes in pediatric DSS. These findings support its utility as a practical and accessible tool for early risk stratification in DSS patients. These results support the use of LAR as a practical and accessible tool for risk stratification in pediatric dengue care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.